177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer.
about
Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [177Lu]Lu-PSMA-617 radioligand therapy.Current status of theranostics in prostate cancer.Delayed response after repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer.Radiotheranostics in Cancer Diagnosis and Management.Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review.PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival.[177Lu-PSMA therapy : Current evidence for use in the treatment of patients with metastatic prostate cancer].External radiation exposure, excretion, and effective half-life in 177Lu-PSMA-targeted therapies.PSMA Theranostics: Current Status and Future Directions.
P2860
Q47158291-5052B02B-F4F9-426E-89FC-1167649AE684Q47241139-B57991B6-6040-4BA4-A352-B441E4F81BD3Q47603267-D16B3085-E6CF-4670-841C-81A55AD93796Q47719762-97C8F089-861F-4770-829E-80ECF5D9BB12Q48107095-D8C216F8-5512-4F96-ABCC-E1EEA572C9CEQ48194472-FB1564ED-48AB-4A17-A31E-C0DAD86E6E6DQ49546570-87C9AABF-2232-4933-BFFF-75FF975DBDE8Q53695831-4BCC55C6-7375-4004-8D07-3C8FCF7F9080Q55023828-13FEBC91-5F7C-40A5-9184-52A154E0933D
P2860
177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
177Lu-PSMA-617 radioligand the ...... ion-resistant prostate cancer.
@en
type
label
177Lu-PSMA-617 radioligand the ...... ion-resistant prostate cancer.
@en
prefLabel
177Lu-PSMA-617 radioligand the ...... ion-resistant prostate cancer.
@en
P2093
P2860
P1476
177Lu-PSMA-617 radioligand the ...... ion-resistant prostate cancer.
@en
P2093
Andres Jan Schrader
Axel Bräuer
Lena Sophie Grubert
Martin Bögemann
Michael Schäfers
Wolfgang Roll
P2860
P2888
P304
P356
10.1007/S00259-017-3751-Z
P577
2017-06-17T00:00:00Z